BSLK (BSLK) Stock Price & Analysis
BSLK (BSLK) rose 0.00% to USD 0 as of September 9, 2026 at 10:11 UTC, according to Nexqual real-time market data.
BSLK last closed at USD 0; the session ranged USD 0–0.01 on volume of 22,500 shares. Market capitalization is $436, with a 52-week range of USD 0–4.44 (PNK). Source: Nexqual, September 9, 2026 at 10:11 UTC.
Key Statistics (as of September 9, 2026 at 10:11 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0.01 |
| 52-Week Range | USD 0 – 4.44 |
| Volume | 22,500 shares |
| Market Cap | $436 |
| Exchange | PNK |
Technical Analysis (BSLK)
Nexqual's technical model rates BSLK "NEUTRAL" based on 3 bullish and 3 bearish signals across 127 daily candles, as of September 9, 2026 at 10:11 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 59.64 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (BSLK)
Wall Street analysts rate BSLK "None", per Nexqual as of September 9, 2026 at 10:11 UTC.
| Consensus Rating | None |
|---|
Earnings (BSLK)
Source: Nexqual, September 9, 2026 at 10:11 UTC.
Financials & Fundamentals (BSLK)
| Total Revenue | $3.14M |
|---|---|
| Revenue Growth (YoY) | +7300.00% |
| Gross Margin | +3.22% |
| Operating Margin | -1179.46% |
| Profit Margin | +0.00% |
| Current Ratio | 0.69 |
| Total Cash | $4.77M |
| Total Debt | $12.91M |
| Free Cash Flow | $2.13M |
Source: Nexqual, September 9, 2026 at 10:11 UTC.
Financial Health Score (BSLK)
Nexqual rates BSLK's overall financial health "Weak" across five dimensions, as of September 9, 2026 at 10:11 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $5M cash vs $13M debt |
| Cash Flow | Weak — Operating cash flow -$5M |
| Efficiency | Mixed — No data |
Ownership (BSLK)
| Insider Ownership | +11.02% |
|---|---|
| Institutional Ownership | +7.34% |
| Shares Outstanding | 4.37M |
| Float | 4.20M |
| Short % of Float | +2.99% |
Source: Nexqual, September 9, 2026 at 10:11 UTC.
Leadership (BSLK)
BSLK is led by Daniel Widmaier (age 44), Co-Founder, Chairman & CEO, per Nexqual as of September 9, 2026 at 10:11 UTC.
| Co-Founder, Chairman & CEO | Daniel Widmaier (age 44) |
|---|---|
| President | Cintia Nardi (age 51) |
| Co-Founder, CTO, Chief Product Officer & Director | David N. Breslauer (age 42) |
| Interim Chief Financial Officer | Randy Befumo |
Major Backers & Investors (BSLK)
Notable institutional backers of BSLK include Baillie Gifford, according to Nexqual as of September 9, 2026 at 10:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Baillie Gifford | 2.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.35% |
Source: Nexqual, September 9, 2026 at 10:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIVF | NewGenIvf Group Limited | USD 1.11 | ▼ 5.93% |
| VTAK | Catheter Precision, Inc. | USD 0.19 | ▼ 4% |
| TWG | Top Wealth Group Holding Limite | USD 0.52 | ▲ 4.26% |
| XPON | Expion Energy, Inc. | USD 5.55 | ▼ 10.48% |
| SKYA | SkyAI, Inc. | USD 1.35 | ▼ 5.94% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 10:11 UTC. This page is informational and not investment advice.